Utah has cleared the first AI system in the United States to issue prescriptions for patients without a physician directly reviewing the prescription before it is submitted. On October 5, 2026, Nolla Health announced that its AI-powered Nolla Derm app received regulatory approval from Utah's Office of Artificial Intelligence Policy to issue initial prescriptions for eight acne medications. This milestone—achieved through the state's regulatory sandbox—marks a significant shift in how artificial intelligence can participate in clinical decision-making, moving beyond prescription renewals into autonomous diagnostic assessment and treatment initiation.
Continue reading
The rest of this article is for AI News Blitz readers. Choose an option below to keep reading.
Already purchased? Sign in✓ Signed in — this article isn’t included in your current plan.
Unlocking the full article...
Contact us
Questions, corrections, or ideas? Send us a message here. We aim to reply by email within 24 hours.
Thank you. Your message has been sent. We aim to reply by email within 24 hours.Please enter your email address and a message.We could not send your message. Please try again in a little while.